Araque AB, Clachar HG, Arce CKM

Language: Spanish
References: 17
Page: 467-471
PDF size: 325.81 Kb.

ABSTRACT

Adenoid cystic carcinoma accounts for approximately 25% of head and neck tumors, located mainly in palate, lips and buccal mucosa. It maintains a slow course but with a potential long term metastasic spread, predominantly vascular and rarely compromises lymph nodes. Clinically it manifest as an indolent mass. The most important tool in diagnosis is physical examination followed with ultrasound and, depending on the characteristics of the tumor, an MRI is required to limit the mass and as a guide during the surgery procedure. The first line of treatment is surgical resection and studies have shown better results with addition of radiotherapy.

REFERENCES

1. Akrish Sharon, et al. Malignant salivary gland tumors and cyclooxygenase- 2: A histopathological and immunohistochemical analysis with implications on histogenesis. Oral Oncology. Elsevier Ltd, 2009. Vol 45: 1044-1050.

2. Aoki Takayuki et al. Hepatocyte growth factor expression correlates with cyclooxygenase-2 pathway in human salivary gland tumors. Oral Oncology. Elsevier Ltd, 2006. Vol 42:51-56.

3. Ávila Esteban et al. Carcinoma adenoide quístico. Presentación de un caso. Revista Española de Patología, 2010. Vol 43:126-128.

4. Dias Fernando et al. Management of tumors of the submandibular and sublingual glands. Salivary Gland disorders. Springer, 2007. 21:339-375.

5. González Frade et al. Proliferación celular en tumores de glándulas salivales. Acta otorrinolaringológica España, 2001. Vol 52:456-460.

6. Guzzo Marco et al. Major and minor salivary gland tumors. Clinical reviews in Oncology/Hematology. Elsevier Ltd, 2010. Vol 74: 134-148.

7. Hsu Amy et al. Indications, techniques, and complications of major salivatory gland extirpation. Elsevier Ltd, 2009. Vol 21:313-321.

8. Ishibashi H. et al. Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncology. Elsevier Ltd, 2001. Vol 37:77-83.

9. Mehra Ranee et al. New agents in the treatment for malignancies of the salivary and thyroid glands. Elsevier Ltd, 2008. Vol 22:1279.1295.

10. Milano Amalia, et al. Recent advances in the treatment of salivary gland cancers: Emphasis on molecular targeted therapy. Oral Oncology. Elsevier Ltd, 2007. Vol 43:729–734.

11. Rubio Alfaro, et al. Carcinoma Adenoide Quístico. Actas Dermosifiliogr, 2006. Vol 97: 578-580.

12. Santiago Sequeiros et al. Prognostic factors in adenoid cystic carcinoma of salivary glands. Acta otorrinolaringología. España,2005. Vol 56:361:367.

13. Sato Mitsunobu. Salivary gland tumors. Human cell culture. Kluwer Academics Publishers, 1999. Vol 1: 161-178.

14. Seethala Raja. An update Grading of Salivary Gland Carcinomas. Head and neck Pathology, 2009. Vol 3:69-77.

15. Strick M.J. et al. Malignant tumours of the minor salivary glands –a 20 year review. The British Association of Plastic Surgeons. Elsevier Ltd, 2004. Vol 57:624-631.

16. Subhashraj Krishnaraj. Salivary gland tumors: a single institution experience in India. Journal of Oral an Maxillofacial Surgery. Elsevier Ltd, 2008. Vol 46:635-638.

17. Targa-Stramandinoli Roberta et al. Neoplasias de glándulas salivares menores: estudio de 10 años. Acta Otorrinolaringológica España, 2009. Vol 60:199-201.